Aktive Positionen von Brian Sun
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TURG POIN | General Counsel | 11.04.2022 | - |
Karriereverlauf von Brian Sun
Ehemalige bekannte Positionen von Brian Sun
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SORRENTO THERAPEUTICS, INC. | General Counsel | - | - |
| Unternehmenssekretär | - | - |
Ausbildung von Brian Sun
| University of San Diego | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| General Counsel | 2 |
| Graduate Degree | 2 |
| Corporate Secretary | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
